[Pheochromocytoma].
Arai
Hiroshi
H
Department of Endocrinology and Metabolism, Kyoto University Graduate School of Medicine.
Nakao
Kazuwa
K
D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D000315:Adrenalectomy; D015415:Biomarkers / Q000032:analysis; D002395:Catecholamines / Q000032:analysis; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D018095:Germ-Line Mutation; D006801:Humans; D009377:Multiple Endocrine Neoplasia / Q000235:genetics; D025542:Neurofibromin 1 / Q000235:genetics; D010673:Pheochromocytoma / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics; D013385:Succinate Dehydrogenase / Q000235:genetics
D015415:Biomarkers; D002395:Catecholamines; D025542:Neurofibromin 1; D013385:Succinate Dehydrogenase; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human